LRK-4189

· Larkspur Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LRK-4189, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors [Phase 1, Phase 2]

See pricing